Reviewer #1: Remarks to the Author: This study aims to determine the role of osteocytic eprhinB2 on bone mineralization. In addition to investigating mineralization patterns in the eprhinB2 deficient mice, the authors performed RNA sequencing and showed differential expression of autophagy-associated genes. This led them to conclude that the process of secondary mineralization uses the autophagy machinery in an eprhinB2-dependent manner. The data appear solid and the description is clear. However, the connection between mineralization defects and autophagy is missing, and no attempt was made to determine whether autophagy dysregulation is responsible for the mouse phenotype or whether modulating autophagy at least in vitro has any consequences on the phenotype of eprhinB2-deficient osteocytes. Without this evidence the data on autophagy is not relevant for the manuscript and it should be removed, and the title should be modified accordingly. Additional issues: 1-The first sentence of the introduction should be modified, since the skeleton is unique not only to the human body, and the authors are actually using a mouse model in their studies.
This study aims to determine the role of osteocytic ephrinB2 on bone mineralization. In addition to investigating mineralization patterns in the ephrinB2 deficient mice, the authors performed RNA sequencing and showed differential expression of autophagyassociated genes. This led them to conclude that the process of secondary mineralization uses the autophagy machinery in an ephrinB2-dependent manner. The data appear solid and the description is clear. However, the connection between mineralization defects and autophagy is missing, and no attempt was made to determine whether autophagy dysregulation is responsible for the mouse phenotype or whether modulating autophagy at least in vitro has any consequences on the phenotype of eprhinB2-deficient osteocytes. Without this evidence the data on autophagy is not relevant for the manuscript and it should be removed, and the title should be modified accordingly.
In response to this comment, we now have new data showing (1) confirmation of increased autophagy in EphrinB2 knockdown osteocytes in vitro (new Figure 7, panels B and C), (2) increased mineralization in cultured EphrinB2-deficient osteocytes (new Figure 7, panels D and E), and (3) abundant autophagosomes and matrix vesicles in EphrinB2 deficient osteocytes in vivo (new Figure 8). This data provides compelling evidence that strongly supports our model proposed in the initial submission. This new data is described at the end of the results section (p12-14), and in some changes to the discussion (p18,19).
Additional issues: 1-The first sentence of the introduction should be modified, since the skeleton is unique not only to the human body, and the authors are actually using a mouse model in their studies. RESPONSE: We have removed the phrase "in the human body" from this sentence.
2-References should be provided for the statement regarding the process of mineralization in the first paragraph of the Introduction.
RESPONSE: We have added the following two references to this statement:
• 3-Second paragraph of the introduction, lines 77-79: the statement should be made more general since not only PTHrP, but also PTH (teriparatide) are used to stimulate bone formation.
RESPONSE: We have clarified this statement in the new version of the manuscript, as follows:
"This PTHR1-mediated action is exploited by the pharmacological agents teriparatide (PTH) and abaloparatide (modified N-terminal PTHrP), the only pharmacological agents currently available that can increase bone mass in patients with fragility fractures 12, 13 ." 4-Minor point: the reviewer cannot find the "full data availability" statement in the manuscript.
RESPONSE: This has been added to the end of the materials and methods section (p37).
The GEO dataset will be made public at the time of publication.
Reviewer #2:
Following a previous sFTIRM study of bone matrix maturation after PTH treatment, this manuscript aims to define the role of ephrinB2 in osteocytes. It shows that osteocytespecific ephrinB2-deficient mice have a brittle bone phenotype. It also provides RNA sequencing data using an osteocyte cell line treated with ephrinB2 knockdown vector and reports that a group of autophagy-associated genes were differentially expressed. It proposes that ephrinB2 is required to restrain autophagy in osteocytes and limits the secondary mineralization process.
Although the role of osteocytes in secondary mineralization is an important area of bone biology considering the limited knowledge about the mechanisms controlling the speed of continuing mineral depositions, this study is too preliminary for multiple reasons. First, it is potentially interesting that knockdown of ephrinB2 affects autophagy-related genes, but the mechanism and significance are not clear. The statement was made that autophagic processes in osteocytes directly control mineralization, but there is no such data shown. Figure 7 , panels B and C), (2) Third, the conclusions of the FTIR measurements are only poorly supported by the data presented. In particular, time-dependent descriptions such as "brittle bone phenotype is therefore associated with more rapid bone matrix maturation, including rapid accumulation of mineral and carbonate substitution and more rapid collagen compaction within the matrix" (page 9) and "both mineral accrual and carbonate substitution within the mineral occur at an accelerated rate in the absence of ephrinB2" (page 13) appear to be overinterpretation of regional data without performing timecourse experiments. 2. Figure 4B and Figure 4E are inconsistent. Wavenumber of Amide I (1588-1712) and Amide II (1500-1600) in Figure 4E is different from the shaded Wavenumber in the FTIRM spectrum ( Figure 4B ). The photo shown in Figure 4A top was previously published by the authors, but this is not mentioned in the legend. Regions should include endocortical as in Figure 5 . Figure 4B were intended as a guide only, as mentioned in the legend ("approximate regions"). To avoid confusion, we have updated the shading to more accurately represent the peaks used for analysis, and clarified the legend.
RESPONSE: We now have new data showing (1) confirmation of increased autophagy in EphrinB2 knockdown osteocytes (new

RESPONSE: The regions shown in
We have replaced the image in Figure 4A with a new photo from the present study. 5. Scale bars are missing from Figure 5A , B, D, and E. RESPONSE: Scale bars have been added.
6. Figure 6D . A break in the Y axis is necessary not to start at 0. Fig. 7D ). 
RESPONSE: Thank you for alerting us to this. This has been corrected (now
Reviewer #3:
In this study, the authors found that osteocyte-specific EphrinB2 knockout mice result in fragile bones could cause brittle bone disease. This phenotype was attributed to defect in bone matrix maturation by unregulated secondary mineralization. Further, the authors revealed that autophagy is enhanced in the osteocytes lacking EphrinB2. On the basis of these results, the authors claim that ephrinB2 inhibits autophagy in osteocytes for generating the appropriate mineralization. While the presented data are of interest, some additional experiments are needed to support the author's claim. 
RESPONSE: Thank you for this suggestion. We have now assessed the osteocyte network using the Ploton silver stain (the Kamioka method was used in embryonic bone which is less mineralized). We compared 6 different regions, including the diaphysis, the region of mature bone with impaired strength and hypermineralization. We observed no difference in the network. This has been included in the new Supplementary Figure 2, and is mentioned in the results section (p8). In addition, because this finding indicated no difference in the dendritic network, we have removed the section of our discussion that suggested that osteocyte differentiation and dendrite formation requires EphrinB2.
5. The authors should investigate the effects of chloroquine on brittle bone by administration of chloroquine to osteocyte-specific EphrinB2 null mouse.
RESPONSE: Systemic inhibition of autophagy with chloroquine would affect all cell types, not only osteocytes. Since systemic treatment with chloroquine has already been noted to reduce osteoclast-mediated bone resorption through direct effects on that lineage (Xiu et al, JCI 2014), and this would protect bone strength, such an intervention in this mouse model would not be helpful.
Responses to Reviewers
Reviewer #1:
This study aims to determine the role of osteocytic ephrinB2 on bone mineralization. In addition to investigating mineralization patterns in the ephrinB2 deficient mice, the authors performed RNA sequencing and showed differential expression of autophagyassociated genes. This led them to conclude that the process of secondary mineralization uses the autophagy machinery in an ephrinB2-dependent manner. The data appear solid and the description is clear. However, the connection between mineralization defects and autophagy is missing, and no attempt was made to determine whether autophagy dysregulation is responsible for the mouse phenotype or whether modulating autophagy at least in vitro has any consequences on the phenotype of ephrinB2-deficient osteocytes. Without this evidence the data on autophagy is not relevant for the manuscript and it should be removed, and the title should be modified accordingly. 
In response to this comment, we now have new data showing: 1. confirmation of increased autophagy in Efnb2 knockdown osteocytes in vitro (new
These new data provide compelling evidence that strongly supports our model proposed in the initial submission. It is described at the end of the results section (p12-14), and in some changes to the discussion (p18,19).
RESPONSE: We have added the following two references to this statement:
• 4-Minor point: the reviewer cannot find the "full data availability" statement in the manuscript.
RESPONSE: This has been added to the end of the materials and methods section (p33).
Reviewer #2:
Although the role of osteocytes in secondary mineralization is an important area of bone biology considering the limited knowledge about the mechanisms controlling the speed of continuing mineral depositions, this study is too preliminary for multiple reasons.
First, it is potentially interesting that knockdown of ephrinB2 affects autophagy-related genes, but the mechanism and significance are not clear. Third, the conclusions of the FTIR measurements are only poorly supported by the data presented. In particular, time-dependent descriptions such as "brittle bone phenotype is therefore associated with more rapid bone matrix maturation, including rapid accumulation of mineral and carbonate substitution and more rapid collagen compaction within the matrix" (page 9) and "both mineral accrual and carbonate substitution within the mineral occur at an accelerated rate in the absence of ephrinB2" (page 13) appear to be overinterpretation of regional data without performing timecourse experiments. (Fig. 3A) ."
Additional points. 2. Figure 4B and Figure 4E are inconsistent. Wavenumber of Amide I (1588-1712) and Amide II (1500-1600) in Figure 4E is different from the shaded Wavenumber in the FTIRM spectrum ( Figure 4B ). The photo shown in Figure 4A top was previously published by the authors, but this is not mentioned in the legend. Regions should include endocortical as in Figure 5 . Figure 4B (now Figure 3B) 
RESPONSE: The regions shown in
were intended as a guide only, as mentioned in the legend ("approximate regions"). To avoid confusion, we have updated the shading to more accurately represent the peaks used for analysis, and clarified the legend.
We have replaced the image in Figure 4A (now Figure 3A) with a new photo from the present study. Figure 3) Figure 1 ) indicates total strength of the bone (without correcting for differences in bone size). It is because we still see a reduction in strength after correcting for bone size (in the stress-strain data -now in Figure 2 ), that we know the defect in strength is a material defect. We have added some information to clarify this in the results section (p6-7) and in the figure legends. Figure 5A , B, D, and E. Figure 4A ,B,D,E).
Figure 4 (now
RESPONSE: Yes, and this is why it is important to show both stress-strain and loaddeformation data. The load-deformation data (now in
Scale bars are missing from
RESPONSE: Scale bars have been added (now
6. Figure 6D . A break in the Y axis is necessary not to start at 0. Fig. 5D ). 
RESPONSE: Thank you for alerting us to this. This has been corrected (now
Reviewer #3:
In this study, the authors found that osteocyte-specific EphrinB2 knockout mice result in fragile bones could cause brittle bone disease. This phenotype was attributed to defect in bone matrix maturation by unregulated secondary mineralization. Further, the authors revealed that autophagy is enhanced in the osteocytes lacking EphrinB2. On the basis of these results, the authors claim that ephrinB2 inhibits autophagy in osteocytes for generating the appropriate mineralization. While the presented data are of interest, some additional experiments are needed to support the author's claim. 3. The authors should show the results of region 1 and 3 in Fig. 4B . Figure 3B) . The authors performed additional experiments to reinforce the autophagy data, which is partly successful. However, the revised manuscript fails because it tries to deliver too much complex information raging from the altered bone matrix material properties to enhanced autophagy mainly in cultured cell line, which do not really answer to the previous comments of this reviewer.
RESPONSE: We have modified this figure to include all three regions (now
(Previous comment) "
The statement was made that autophagic processes in osteocytes MAY directly control mineralization, but there is no such data shown."
The authors claim that new data shows "abundant autophagosomes and matrix vesicles in Dmp1Cre.Efnb2f/f osteocytes in vivo (new Figure 7) " without showing evidence that these structures are matrix vesicles. Are they loaded with calcium and inorganic phosphate ions?
2. (Previous comment) "Second, the high osteocyte lacuna density in the absence of ephrinB2 remains descriptive."
The authors' finding of the greater osteocyte lacunar density in Dmp1Cre.Efnb2f/f bone is interesting and potentially affects mechanical properties of bone. At least, quantitative discussion is necessary whether the higher lacunae density contributes observed differences in bone mechanical properties.
3. (Previous comment) "Third, the conclusions of the FTIR measurements are only poorly supported by the data presented."
The authors' claim that "Unlike the endocortical surface, which is remodeled, the periosteal surface at this location undergoes continuous bone formation (bone growth), without bone resorption (Ref. 20)" is not supported by data.
(Previous comment) "Why was a strength defect detectable only in females?
Were there any sex differences in other experiments?"
In the revised manuscript, the authors made a very interesting observation that male Dmp1Cre.Efnb2f/f femora showed no significant modification in 222 mineral:matrix, carbonate:mineral or amide I:II ratio (Supplementary Figure 1) . This indicates that observed sex difference in mechanical properties is not simply due to geometry differences of bone but due to fundamental differences in bone matrix properties between females and males. Female-male differences in other experiments including autophagy aspects should be further analyzed.
(Previous comment) "Does the upregulation of ephrinB2 expression by PTH treatment reduce susceptibility of osteocytes to autophagy?"
This comment is not addressed by the authors.
6. The new scheme Figure 9 : Model of osteocytic EphrinB2 regulation of bone matrix composition" is difficult to follow. Why mineral crystals are accumulating far away from autophagic osteocytes.
7. The references are not well selected (too many).
Reviewer #3: Remarks to the Author: In the revised manuscript, the authors have addressed and expressed my concerns raised in the previous review. I think the present manuscript is acceptable for publication in Nature Communications.
Both Reviewer 1 and Reviewer 3 requested no further modifications.
Responses to Reviewer 2:
1. COMMENT: The authors claim that new data shows "abundant autophagosomes and matrix vesicles in Dmp1Cre.Efnb2f/f osteocytes in vivo (new Figure 7) " without showing evidence that these structures are matrix vesicles. Are they loaded with calcium and inorganic phosphate ions?
RESPONSE: The presence of calcium and inorganic phosphate ions is not a defining feature of matrix vesicles. Matrix vesicles are simply extracellular membrane-invested particles released by budding from the surfaces of matrix-associated cells, including chondrocytes, osteoblasts, odontoblasts and osteocytes (see HC Anderson, Clin Orthop Rel Res 1995). These are clearly observed in Figure 7 . We suspect the matrix vesicles in our images contain mineral, but confirming this will be very challenging and requires extensive experiments beyond the scope of this study. Figure 2) ".
COMMENT:
In the revised manuscript, the authors made a very interesting observation that male Dmp1Cre.Efnb2f/f femora showed no significant modification in mineral:matrix, carbonate:mineral or amide I:II ratio (Supplementary Figure 1) . This indicates that observed sex difference in mechanical properties is not simply due to geometry differences of bone but due to fundamental differences in bone matrix properties between females and males. Female-male differences in other experiments including autophagy aspects should be further analyzed.
RESPONSE: We agree that the difference in mechanical properties is unlikely to be due to geometry differences, but is due to baseline differences in bone matrix composition between females and males. Given that the male Dmp1Cre.Efnb2f/f femora show no strength phenotype, it would be very difficult to justify the use of additional animals to specifically validate whether they also exhibit no change in autophagy in their osteocytes. We have clarified our comment about sex differences in the discussion, as follows: "We suggest that changes in bone matrix composition may play a more significant role in determining bone strength in female bones because they have higher mineral content and more rapid bone remodeling than male bones."
5. COMMENT: "Does the upregulation of ephrinB2 expression by PTH treatment reduce susceptibility of osteocytes to autophagy?". This comment is not addressed by the authors.
RESPONSE: As we stated in the previous response, we plan to assess the effects of PTH treatment on autophagy. This requires an extensive set of in vivo experiments, which is beyond the scope of the current work.
Given that pharmacologic PTH treatment does not modify the mineralization process (Vrahnas et al, Bone 2016), we had commented in the discussion that, in a physiological context, any PTH1R-mediated action on autophagy is more likely to relate to actions of endogenous PTHrP. See p20, end of first paragraph, included here for convenience: We have added a section to the discussion describing limitations of current osteocyte culture methods and the requirement for developing systems where osteocytes are embedded in a mineralized collagen-containing matrix (p19). We have added a section to the discussion to clarify that there is no association with increased Atg-dependent autophagy, but with ER-phagy, and to inform readers that the direct role of ER-phagy in mineral release is not something that can yet be tested experimentally (p18, first paragraph). We have modified the discussion to include the definition of matrix vesicles, and describe the current controversies regarding the mechanisms of mineral release (p18 second paragraph). We have also modified the final schematic figure (panel C) to omit the mineral within the vesicles prior to release, since is a hypothesis arising from the work.
Regarding the request to change our description to refer to extracellular vesicles
